8-KEarnings & ResultsExhibits & Filings

Guardant Health, Inc. 8-K Report, Financial Results (May 5, 2022)

Filed May 5, 2022For Securities:GH

Summary

Guardant Health, Inc. (GH) announced its financial results for the fiscal quarter ended March 31, 2022, via a press release filed on May 5, 2022. While the 8-K filing itself does not contain the detailed financial figures, it directs investors to the furnished press release (Exhibit 99.1) for this information. This means investors need to consult the press release for key performance indicators such as revenue, net income/loss, earnings per share, and any forward-looking guidance provided by the company for the upcoming periods. The filing also includes a standard disclaimer stating that the information furnished in the press release is not deemed "filed" under Section 18 of the Exchange Act, which limits its liability implications. However, it is incorporated by reference into the report, making it a crucial document for understanding Guardant Health's recent performance and outlook. Investors should pay close attention to the details within the press release to assess the company's operational and financial health.

Key Highlights

  • 1Guardant Health announced Q1 2022 financial results on May 5, 2022, via a press release.
  • 2Detailed financial results and performance metrics are contained within the furnished press release (Exhibit 99.1).
  • 3The 8-K filing incorporates the press release by reference, making it essential reading for investors.
  • 4Information furnished in the press release is not considered 'filed' under Section 18 of the Exchange Act.
  • 5Investors should review Exhibit 99.1 for specific revenue, profitability, and guidance details.
  • 6The filing serves as the official notification of the company's quarterly financial outcomes.

Frequently Asked Questions

The specific financial results for the quarter ended March 31, 2022, are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for figures related to revenue, net income/loss, and other key financial metrics.

The disclaimer means that while the information is being provided to the public through the SEC filing, it does not carry the same legal implications under Section 18 of the Securities Exchange Act of 1934 as information that is formally 'filed'. This typically means it's not subject to liability for misstatements or omissions under that specific section, though it is still incorporated by reference into the report.

This 8-K filing itself does not contain forward-looking guidance. Any guidance provided by Guardant Health for future periods would be included in the press release (Exhibit 99.1) that is furnished with this report.

The most important takeaway is that Guardant Health has officially reported its Q1 2022 financial results. Investors must consult the accompanying press release (Exhibit 99.1) to understand the company's performance, including revenue growth, profitability trends, and any updated outlook, which are critical for investment decisions.